Published on GHDx (https://ghdx.healthdata.org.)

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events

General Info

Geography 
Global
Time period covered 
January, 2012 - December, 2015
Data type
Scientific literature
Keywords 
Cholesterol, Risk factors

Citation

Authors 
Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJP, ODYSSEY LONG TERM Investigators
Journal 
N Engl J Med
Pages 
1489-99
Publication year 
2015
Suggested citation 
Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJP, ODYSSEY LONG TERM Investigators. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015; 372(16): 1489-99.
Source URL:https://ghdx.healthdata.org./record/efficacy-and-safety-alirocumab-reducing-lipids-and-cardiovascular-events#comment-0